Percutaneous embolotherapy of XXXX .

@entity1 @entity548 @entity63 @entity887 @entity1188 @entity360
PURPOSE: To evaluate percutaneous embolotherapy in the treatment of @entity360 . MATERIALS AND METHODS: Twenty-one @entity1 who underwent attempted percutaneous embolization for @entity360 between 1982 and 1997 were retrospectively studied. @entity548 sites included jejunum (n = 4), ileum (n = 4), cecum (n = 4), and the remaining colon (n = 9). RESULTS: Embolization was not technically possible in four @entity1 (19%). Hemostasis was achieved in 15 @entity1 (71%) with prolonged hemostasis in 10 (48%). All @entity887 distal to the cecum resulted in prolonged hemostasis. Three of four @entity1 with @entity548 had recurrent @entity548 after apparent successful embolization. Only one of four cecal @entity887 achieved prolonged cessation of @entity548 . No @entity63 complications were identified. CONCLUSION: Based on these data, it would appear that the risk of @entity63 / @entity1188 in the lower gastrointestinal tract may not be as high as has been suggested. Two regions (cecum and proximal jejunum) were associated with poor results, suggesting these areas may not be as responsive to embolotherapy as other sites in the lower gastrointestinal tract.
